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Benign familial infantile convulsions (BFIC) are an
autosomal-dominant epileptic syndrome characterized
by an age of onset within the first year of life. Although
they were first reported in families of Italian descent,
BFIC have also been described in non-Italian families.
We have mapped the BFIC gene to chromosome 19 by
linkage analysis in five Italian families with a maximum
two-point lod score of 6.36 at D19S114; maximum
multipoint lod scores >8 were obtained for the interval
D19S250-D19S245. BFIC are therefore the third
idiopathic partial epileptic syndrome to be mapped on
the human genome.
INTRODUCTION
Epilepsy is one of the most common neurological disorders with
a cumulative incidence of -2% in the general population by age
40 (1). However, despite intense research, its basic pathogenetic
mechanisms remain poorly known. As several lines of evidence
suggest an important genetic contribution to the etiology of the
epilepsies, gene mapping is potentially an important experimental
approach for understanding the molecular basis of these disorders
(2). Gene-mapping studies, however, work best when the
phenotype can be determined accurately and when the disease
gene is highly penetrant (2). Consequently, genetic linkage
analysis of epileptic syndromes with a Mendelian mode of
inheritance, as a first step in order to clone the responsible genes
and define their protein product, is now one of the most promising
approaches in identifying the pathogenetic mechanisms
underlying epilepsies.
Mendelian epileptic diseases are rare in human. To date only
one syndrome with an autosomal-dominant mode of inheritance
has been recognized among the idiopathic epilepsies in the
International Classification of Epilepsies (3): the benign familial
neonatal convulsions (BFNC). Linkage of BFNC to chromosome
20q has been initially reported (EBN1; 4,5) and evidence for
non-allelic genetic heterogeneity has been demonstrated by
linkage mapping of a second BFNC locus to chromosome 8q
(EBN2; 6). Mapping of the other most common idiopathic
epilepsies is difficult because of age-dependent penetrance,
spontaneous remission and clinical heterogeneity within the same
pedigree. These difficulties have been responsible for the discrep-
ancies between the linkage studies of juvenile myoclonic epilepsy
(JME) (7).
Benign familial infantile convulsions (BFIC) is a recently
recognized idiopathic epileptic syndrome with an autosomal-
dominant mode of transmission (8). BFIC was originally described
in families of Italian ancestry (8). The disease has also been
reported in other Italian (9) and non-Italian families, in France
(10,11), Singapore (12), Sweden (Liiovigson, personal
communication), Germany (Dr Kurlemann, personal communi-
cation) and the United States of America (Dr Ryan, personal
communication). BFIC presents with onset between 3.5 and 12
months, seizures of partial type in most cases (according to ictal
EEG recordings), no etiological factors, normal psychomotor
development, and normal interictal electroencephalograms (EEGs)
(8). BFIC is inherited in a manner consistent with an autosomal
dominant disorder (8).
To initiate studies that should lead to the identification of the
gene defect responsible for BFIC, genetic linkage analysis was
performed in five kindreds with this disorder. As a first step, we
have used a candidate gene approach in performing linkage
analysis using microsatellite polymorphisms flanking the
previously mapped epilepsy genes. Due to some similar clinical
features between BFNC and BFIC (epileptic syndrome with no
etiological factors, normal psychomotor development, normal
interictal electroencephalograms, and autosomal dominant mode
of inheritance) we first analysed the EBN1 region. This region has
been excluded (13) as well as all other candidate regions so far
analysed (unpublished data). Consequently, a systematic
approach using microsatellite polymorphisms lying in non-
excluded regions has been used. We now report that the gene for
BFIC maps to the long arm of chromosome 19 in our five
pedigrees.
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RESULTS
Over 40 microsatellites lying in non-excluded regions were
genotyped before linkage was detected. Two-point maximum
likelihood calculations were performed after each complete
genotyping with one marker. We detected one microsatellite
polymorphism giving a maximum two-point lod score of 5.16 at
0 centiMorgan from the marker locus DJ9S250. This prompted
us to study chromosome 19q with additional markers. Based on
their position reported by Weber et al. (14), five other
microsatellite markers (DJ9S49, D19S1J4, D19S249, D19S25I
and D19S245) on chromosome 19 were studied. The results of
two-point maximum likelihood calculations between the disease
phenotype and each of the marker loci are shown in Table 1, and
the pedigree genotyping data for these markers are summarized
in Figure 1. Haplotype analysis (Figs 1 and 2), two-point lod
scores (Table 1), and multipoint analyses (maximum multipoint
lod scores >8 obtained for the interval DI9S250-DJ9S245)
suggested that BFIC is linked to chromosome 19 in the five
pedigrees. Moreover, haplotype analysis showed that there may
be a common haplotype in Families \-A (Fig. 2). Combined with
the fact that these 19q-linked families represent a homogeneous
group of pedigrees, since they are from Italian descent and
seizures recorded in all probands are of partial type (8), this result
may indicate the existence of a founder effect.
Table 1. Cumulative and pedigree-specific two-point lod scores for benign familial infantile convulsions versus chromosome 19 markers
Locus
D19S49
1
2
3
4
5
DI9S250
1
2
3
4
5
DI9SII4
1
2
3
4
5
DI9S249
1
2
3
4
5
DI9S251
1
2
3
4
5
DI9S245
1
2
3
4
5
Recombination
0.00
- c o
1.51
1.64
1.51
—OO
0.90
5.16
0.30
1.64
1.51
1.03
0.69
6.36
0.90
1.37
1.51
1.67
0.90
5.40
0.30
1.03
1.51
2.04
0.52
4.73
0.30
0.74
1.51
1.28
0.90
5.21
1.51
1.44
0.60
0.76
0.90
fraction
0.05
4.98
1.37
1.48
1.37
-0.08
0.84
4.63
0.26
1.48
1.37
0.90
0.62
5.76
0.82
1.23
1.37
1.51
0.84
4.86
0.26
0.92
1.37
1.85
0.46
4.28
0.26
0.67
1.37
1.14
0.84
4.73
1.37
1.29
0.54
0.69
0.84
0.10
4.66
1.24
1.32
1.23
0.11
0.77
4.08
0.21
1.32
1.23
0.76
0.55
5.14
0.73
1.08
1.23
1.34
0.77
4.28
0.21
0.80
1.23
1.64
0.40
3.81
0.21
0.60
1.23
1.00
0.77
4.23
1.24
1.14
0.47
0.62
0.77
0.20
3.64
0.95
0.98
0.93
0.18
0.61
3.64
0.13
0.98
0.93
0.48
0.40
3.84
0.54
0.78
0.93
0.98
0.61
3.09
0.13
0.56
0.93
1.21
0.26
2.84
0.13 '
0.46
0.93
0.70
0.61
3.17
0.95
0.82
0.32
0.47
0.61
0.30
2.43
0.65
0.61
0.61
0.12
0.44
2.43
0.06
0.61
0.61
0.23
0.25
2.49
0.36
0.48
0.61
0.60
0.44
1.89
0.06
0.32
0.61
0.76
0.14
1.82
. 0.06
0.32
0.61
0.39
0.44
2.08
0.65
0.50
0.17
0.32
0.44
0.40
1.15
0.33
0.26
0.29
0.04
0.24
1.15
0.02
0.26
0.29
0.05
0.10
1.16
0.18
0.21
0.29
0.25
0.24
0.76
0.02
0.10
0.29
0.31
0.04
0.83
0.02
0.16
0.29
0.12
0.24
1.00
0.33
0.22
0.05
0.17
0.24
Zmax
4.98 0.05
5.16 0.00
6.36 0.00
5.40 0.00
4.73 0.00
5.21 0.00
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Figure 1. The observed alleles with markers D19S49, DI9S250, DI9SI14, D19S249, DI9S25I and DI9S245 in five BFIC families. The phasing of haplotypes was
inferred as most likely using all available genotype data for the families. The segment of conserved disease-bearing chromosome inherited by a member is contained
within the rectangle. The pedigree designations for all families are consistent with those used previously (13). (A.O.C.O: apparent obligate cross-over).
DISCUSSION
We mapped BFIC to chromosome 19q, with no evidence of
heterogeneity within our family sample. The main clinical
features of BFIC (afebrile seizures between 3.5 and 12 months of
age, normal neurodevelopmental status, normal interictal electro-
encephalogram and no demonstrable underlying pathology) led
us to consider this syndrome as an idiopathic epilepsy. Thus BFIC
follows autosomal dominant nocturnal frontal epilepsy (15) and
a partial epileptic syndrome with auditory features (16) as the
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Figure 2. Haplotypes on benign familial infantile convulsions chromosomes
for D19S49, D19S250, DJ9S114, D19S249, DJ9S25I and D19S245.
third form of inherited idiopathic epilepsy that has had its disease
locus genetically mapped. These results confirm the genetic basis,
the autosomal inheritance and the accuracy of the clinical
diagnostic criteria of BFIC. Moreover, the mapping of the BFIC
gene on a different chromosome from BFNC definitively
demonstrates that these two idiopathic epilepsies are not allelic,
and thus confirm our previous results (13) which indicated that
this epileptic syndrome is distinct from 20q-linked BFNC.
The existence of a founder effect in these Italian 19q-linked
BFIC families is suggested by the common haplotype found in
our pedigrees (Fig. 2). Haplotypes in pedigrees 4 and 5 may
indicate that the BFIC gene is located between D19S114 and
D19S249. However, to confirm this hypothesis a larger number
of Italian families and more genealogical information from the
pedigrees is required.
Clinical characteristics may indicate that BFIC is a
localisation-related epilepsy. The implication of this locus in
other inherited IPE remains to be tested. Because of the occipital
discharges observed in 19q-l inked BFIC, benign occipital
epilepsy, which is characterized by an age of onset between 4 and
8 years and an autosomal dominant mode of inheritance (17),
should represent a good candidate for such studies.
It is currently impossible to determine whether the different
kinds of seizures in BFNC and BFIC are directly caused by the
responsible genes or are in fact the result of interactions between
them and different developmental factors. Conversely, the
specific ages of onset of BFNC and BFIC may indicate that the
corresponding genes play a role in the maturation of regulatory
processes of cerebral excitability.
The next step will be to narrow down the BFIC region, and
identify candidate genes from these regions. Thus, the
identification of the gene defect responsible for BFIC may
provide new and unsuspected clues into the mechanisms by
which neuronal excitability is regulated.
MATERIALS AND METHODS
Clinical description
The five pedigrees included in the present study (Fig. 1) have
been previously described (13). Family 7 from Malafosse et al.
(13) has not been included because of insufficient data and the
impossibility of obtaining additional information. Blood samples
were obtained from 16 new individuals, and clinical information
was updated for five individuals from Families 1, 3 and 5 (13).
The salient distinguishing clinical features of BFIC are the onset
of seizures between 3.5 and 12 months of age, and normal
psychomotor development (8).
Strategies in the search for linkage and genetic marker
typing
EDTA blood samples (20 ml) were collected and DNA was
prepared from isolated lymphocytes by SDS lysis, proteinase K
digestion, phenol/chloroform extraction, ethanol precipitation and
Tris-EDTA resuspension. Using the polymerase chain reaction
(PCR), hypervariable microsatellites flanking loci responsible for
BFNC (4,6), JME (7) and progressive myoclonus epilepsies (18)
were assessed in a first attempt to localize the BIFC gene. Due to
the exclusion of these candidate regions, other microsatellites from
the Genethon collection (19) and developed by other authors were
further investigated. Polymorphism analysis was performed by
PCR amplifications in 12 |il containing 50-100 ng of genomic
DNA, 1.5 mM MgCl2,100 pmols of each primer, 1.25 mM of each
dNTPs, 0.5 u.Ci [oc-32P]dCTP and 0.25 U Taq polymerase
(Amersham). Amplification conditions were 95 °C for 10 min
followed by 30 cycles at 94 °C for 30 s, specific annealing
temperature and duration for each primers, 72°C for 30 s and a
final extension of 10 min at 72 °C. Amplified DNA (1 \i\) was
mixed with 2 (il formamide and 0.4 ju,l loading buffer (xylene
cyanol/bromophenol blue/glycerol), electrophoresed at 1400 V for
2 h in 6% denaturing polyacrylamide gels. The dried gel was
exposed to X-ray film for 4-18 h at -70°C.
Linkage analysis
Linkage analysis was performed using the M-LINK and
LINKMAP options of the 5.1 version of the LINKAGE program
(20). LOD score values were calculated under the assumption of
single-gene autosomal dominant inheritance with a complete
penetrance and a gene frequency of 0.001 for the BIFC allele, in
view of the low prevalence of this condition. Distances between
marker loci used in the multipoint linkage analysis were those
estimated by Weber et al. (14).
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